questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Oxidoreductases
Oxygénases
Dioxygenases
Indoleamine-pyrrole 2,3,-dioxygenase
Indoleamine-pyrrole 2,3,-dioxygenase : Questions médicales fréquentes
Termes MeSH sélectionnés :
Randomized Controlled Trials as Topic
Diagnostic
5
Diagnostic
Tryptophane
Enzymes
Tests de laboratoire
Enzymes
Métabolisme
Biomarqueurs
Kynurénine
Enzymes
Symptômes
Dépression
Système immunitaire
Symptômes
5
Fatigue
Troubles de l'humeur
Système immunitaire
Santé mentale
Dépression
Enzymes
Troubles auto-immuns
Cancer
Enzymes
Inflammation
Réponses immunitaires
Enzymes
Douleurs chroniques
Troubles métaboliques
Enzymes
Prévention
5
Prévention
Mode de vie
Alimentation
Stress
Santé mentale
Enzymes
Habitudes de vie
Méditation
Exercice
Suppléments alimentaires
Acides gras
Enzymes
Traitements
5
Inhibiteurs
Cancer
Traitements
Alimentation
Tryptophane
Enzymes
Thérapies immunologiques
Inhibition
Système immunitaire
Antidépresseurs
Dépression
Enzymes
Compléments alimentaires
Mélatonine
Enzymes
Complications
5
Complications
Troubles auto-immuns
Cancer
Maladies
Dépression
Anxiété
Effets secondaires
Traitements
Gastro-intestinaux
Maladies neurodégénératives
Alzheimer
Sclérose en plaques
Complications psychologiques
Troubles de l'humeur
Anxiété
Facteurs de risque
5
Facteurs de risque
Stress
Maladies chroniques
Âge
Enzymes
Facteurs de risque
Maladies auto-immunes
Enzymes
Facteurs de risque
Mode de vie
Sédentarité
Alimentation
Facteurs environnementaux
Toxines
Enzymes
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Indoleamine-pyrrole 2,3,-dioxygenase : Questions médicales les plus fréquentes",
"headline": "Indoleamine-pyrrole 2,3,-dioxygenase : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Indoleamine-pyrrole 2,3,-dioxygenase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-03",
"dateModified": "2025-02-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Indoleamine-pyrrole 2,3,-dioxygenase"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Dioxygenases",
"url": "https://questionsmedicales.fr/mesh/D049308",
"about": {
"@type": "MedicalCondition",
"name": "Dioxygenases",
"code": {
"@type": "MedicalCode",
"code": "D049308",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.416"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Indoleamine-pyrrole 2,3,-dioxygenase",
"alternateName": "Indoleamine-Pyrrole 2,3,-Dioxygenase",
"code": {
"@type": "MedicalCode",
"code": "D050503",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ute F Röhrig",
"url": "https://questionsmedicales.fr/author/Ute%20F%20R%C3%B6hrig",
"affiliation": {
"@type": "Organization",
"name": "Molecular Modeling Group , SIB Swiss Institute of Bioinformatics , 1015 Lausanne , Switzerland."
}
},
{
"@type": "Person",
"name": "Vincent Zoete",
"url": "https://questionsmedicales.fr/author/Vincent%20Zoete",
"affiliation": {
"@type": "Organization",
"name": "Molecular Modeling Group , SIB Swiss Institute of Bioinformatics , 1015 Lausanne , Switzerland."
}
},
{
"@type": "Person",
"name": "Khoa N Pham",
"url": "https://questionsmedicales.fr/author/Khoa%20N%20Pham",
"affiliation": {
"@type": "Organization",
"name": "Department of Physiology and Biophysics, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, United States."
}
},
{
"@type": "Person",
"name": "Ariel Lewis-Ballester",
"url": "https://questionsmedicales.fr/author/Ariel%20Lewis-Ballester",
"affiliation": {
"@type": "Organization",
"name": "Department of Physiology and Biophysics, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, United States."
}
},
{
"@type": "Person",
"name": "Syun-Ru Yeh",
"url": "https://questionsmedicales.fr/author/Syun-Ru%20Yeh",
"affiliation": {
"@type": "Organization",
"name": "Department of Physiology and Biophysics, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, United States."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Topical diquafosol versus hyaluronic acid for the treatment of dry eye disease: a meta-analysis of randomized controlled trials.",
"datePublished": "2023-05-10",
"url": "https://questionsmedicales.fr/article/37162564",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00417-023-06083-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "The UPDATE trial (UVB Phototherapy in Dermatology for ATopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczema.",
"datePublished": "2024-07-16",
"url": "https://questionsmedicales.fr/article/39014498",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13063-024-08334-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Design and Methodological Issues of Within-Person (Split-Body) Randomized Controlled Trials Evaluating a Topical Treatment: A Systematic Review.",
"datePublished": "2023-03-29",
"url": "https://questionsmedicales.fr/article/36990057",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000530149"
}
},
{
"@type": "ScholarlyArticle",
"name": "Laser and light therapy combined with topical minoxidil for alopecia areata: a systematic review and meta-analysis of randomized controlled trials.",
"datePublished": "2023-02-17",
"url": "https://questionsmedicales.fr/article/36800063",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10103-023-03734-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Nd:YAG/Er:YAG dual laser vs. topical steroid to treat vulvar lichen sclerosus: study protocol of a randomized controlled trial.",
"datePublished": "2023-05-05",
"url": "https://questionsmedicales.fr/article/37145134",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00404-023-07055-z"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Oxidoreductases",
"item": "https://questionsmedicales.fr/mesh/D010088"
},
{
"@type": "ListItem",
"position": 5,
"name": "Oxygénases",
"item": "https://questionsmedicales.fr/mesh/D010105"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dioxygenases",
"item": "https://questionsmedicales.fr/mesh/D049308"
},
{
"@type": "ListItem",
"position": 7,
"name": "Indoleamine-pyrrole 2,3,-dioxygenase",
"item": "https://questionsmedicales.fr/mesh/D050503"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Indoleamine-pyrrole 2,3,-dioxygenase - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Indoleamine-pyrrole 2,3,-dioxygenase",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Indoleamine-pyrrole 2,3,-dioxygenase",
"description": "Comment diagnostiquer une activité élevée de l'IDO ?\nQuels tests sont utilisés pour évaluer l'IDO ?\nL'IDO est-il associé à des biomarqueurs spécifiques ?\nPeut-on mesurer l'IDO dans les tissus ?\nQuels symptômes peuvent indiquer une dysrégulation de l'IDO ?",
"url": "https://questionsmedicales.fr/mesh/D050503?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Indoleamine-pyrrole 2,3,-dioxygenase",
"description": "Quels sont les symptômes d'une suractivation de l'IDO ?\nL'IDO affecte-t-il la santé mentale ?\nQuels troubles sont liés à l'IDO ?\nL'IDO influence-t-il l'inflammation ?\nDes symptômes physiques sont-ils liés à l'IDO ?",
"url": "https://questionsmedicales.fr/mesh/D050503?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Indoleamine-pyrrole 2,3,-dioxygenase",
"description": "Comment prévenir une dysrégulation de l'IDO ?\nLe stress influence-t-il l'IDO ?\nDes habitudes de vie peuvent-elles réduire l'IDO ?\nL'évitement de certaines substances aide-t-il l'IDO ?\nLes suppléments alimentaires peuvent-ils aider ?",
"url": "https://questionsmedicales.fr/mesh/D050503?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Indoleamine-pyrrole 2,3,-dioxygenase",
"description": "Quels traitements ciblent l'IDO ?\nL'alimentation peut-elle influencer l'IDO ?\nDes thérapies immunologiques ciblent-elles l'IDO ?\nLes antidépresseurs affectent-ils l'IDO ?\nY a-t-il des traitements naturels pour l'IDO ?",
"url": "https://questionsmedicales.fr/mesh/D050503?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Indoleamine-pyrrole 2,3,-dioxygenase",
"description": "Quelles complications sont liées à l'IDO ?\nL'IDO peut-elle aggraver des maladies existantes ?\nDes effets secondaires des traitements de l'IDO existent-ils ?\nL'IDO est-elle impliquée dans des maladies neurodégénératives ?\nDes complications psychologiques peuvent-elles survenir ?",
"url": "https://questionsmedicales.fr/mesh/D050503?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Indoleamine-pyrrole 2,3,-dioxygenase",
"description": "Quels sont les facteurs de risque pour l'IDO ?\nL'âge influence-t-il l'activité de l'IDO ?\nLes maladies auto-immunes augmentent-elles le risque d'IDO ?\nLe mode de vie influence-t-il l'IDO ?\nDes facteurs environnementaux affectent-ils l'IDO ?",
"url": "https://questionsmedicales.fr/mesh/D050503?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une activité élevée de l'IDO ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins mesurant les niveaux de tryptophane et de ses métabolites peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'IDO ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests d'activité enzymatique et les dosages de métabolites sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "L'IDO est-il associé à des biomarqueurs spécifiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des biomarqueurs comme le kynurénine sont souvent associés à l'activité de l'IDO."
}
},
{
"@type": "Question",
"name": "Peut-on mesurer l'IDO dans les tissus ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des biopsies peuvent être analysées pour évaluer l'expression de l'IDO dans les tissus."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une dysrégulation de l'IDO ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fatigue, la dépression et des troubles immunitaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une suractivation de l'IDO ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, troubles de l'humeur, et dysfonction immunitaire peuvent être observés."
}
},
{
"@type": "Question",
"name": "L'IDO affecte-t-il la santé mentale ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une activité élevée de l'IDO est liée à des troubles comme la dépression."
}
},
{
"@type": "Question",
"name": "Quels troubles sont liés à l'IDO ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles auto-immuns et des cancers peuvent être associés à une dysrégulation de l'IDO."
}
},
{
"@type": "Question",
"name": "L'IDO influence-t-il l'inflammation ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IDO joue un rôle dans la modulation des réponses inflammatoires dans l'organisme."
}
},
{
"@type": "Question",
"name": "Des symptômes physiques sont-ils liés à l'IDO ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs chroniques et des troubles métaboliques peuvent être présents."
}
},
{
"@type": "Question",
"name": "Comment prévenir une dysrégulation de l'IDO ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain, avec une alimentation équilibrée et de l'exercice, peut aider."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il l'IDO ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut augmenter l'activité de l'IDO et affecter la santé mentale."
}
},
{
"@type": "Question",
"name": "Des habitudes de vie peuvent-elles réduire l'IDO ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des pratiques comme la méditation et l'exercice régulier peuvent réduire l'IDO."
}
},
{
"@type": "Question",
"name": "L'évitement de certaines substances aide-t-il l'IDO ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'alcool et le tabac peut contribuer à une meilleure régulation de l'IDO."
}
},
{
"@type": "Question",
"name": "Les suppléments alimentaires peuvent-ils aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains suppléments comme les acides gras oméga-3 peuvent moduler l'IDO."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent l'IDO ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs de l'IDO sont en cours d'évaluation pour traiter certains cancers et troubles."
}
},
{
"@type": "Question",
"name": "L'alimentation peut-elle influencer l'IDO ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en tryptophane peut moduler l'activité de l'IDO."
}
},
{
"@type": "Question",
"name": "Des thérapies immunologiques ciblent-elles l'IDO ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines thérapies immunologiques visent à inhiber l'IDO pour améliorer la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Les antidépresseurs affectent-ils l'IDO ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains antidépresseurs peuvent influencer l'activité de l'IDO et améliorer les symptômes dépressifs."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels pour l'IDO ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des compléments comme la mélatonine peuvent avoir un effet modulateur sur l'IDO."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées à l'IDO ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des troubles auto-immuns et des cancers peuvent survenir."
}
},
{
"@type": "Question",
"name": "L'IDO peut-elle aggraver des maladies existantes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une activité élevée de l'IDO peut exacerber des maladies comme la dépression et l'anxiété."
}
},
{
"@type": "Question",
"name": "Des effets secondaires des traitements de l'IDO existent-ils ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains traitements peuvent entraîner des effets secondaires comme des troubles gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "L'IDO est-elle impliquée dans des maladies neurodégénératives ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IDO est associée à des maladies comme la maladie d'Alzheimer et la sclérose en plaques."
}
},
{
"@type": "Question",
"name": "Des complications psychologiques peuvent-elles survenir ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de l'humeur et des troubles anxieux peuvent être exacerbés par l'IDO."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour l'IDO ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme le stress, l'alimentation déséquilibrée et des maladies chroniques augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il l'activité de l'IDO ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge avancé peut être associé à une augmentation de l'activité de l'IDO."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes augmentent-elles le risque d'IDO ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies auto-immunes peuvent être liées à une activité accrue de l'IDO."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il l'IDO ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter l'activité de l'IDO."
}
},
{
"@type": "Question",
"name": "Des facteurs environnementaux affectent-ils l'IDO ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines environnementales peut influencer l'activité de l'IDO."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 26/02/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Molecular Modeling Group , SIB Swiss Institute of Bioinformatics , 1015 Lausanne , Switzerland.
Publications dans "Indoleamine-pyrrole 2,3,-dioxygenase" :
3 publications dans cette catégorie
Affiliations :
Molecular Modeling Group , SIB Swiss Institute of Bioinformatics , 1015 Lausanne , Switzerland.
Department of Fundamental Oncology , University of Lausanne, Ludwig Lausanne Branch , 1066 Epalinges , Switzerland.
Publications dans "Indoleamine-pyrrole 2,3,-dioxygenase" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology and Biophysics, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, United States.
Publications dans "Indoleamine-pyrrole 2,3,-dioxygenase" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology and Biophysics, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, United States.
Publications dans "Indoleamine-pyrrole 2,3,-dioxygenase" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology and Biophysics, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, United States.
Publications dans "Indoleamine-pyrrole 2,3,-dioxygenase" :
2 publications dans cette catégorie
Affiliations :
Lankenau Institute for Medical Research, 100 Lancaster Ave, Wynnewood, PA 19096, USA; Department of Pathology, Anatomy & Cell Biology and, Philadelphia, PA 19104, USA; Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19104, USA. Electronic address: prendergast@limr.org.
Publications dans "Indoleamine-pyrrole 2,3,-dioxygenase" :
2 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
Publications dans "Indoleamine-pyrrole 2,3,-dioxygenase" :
2 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
Publications dans "Indoleamine-pyrrole 2,3,-dioxygenase" :
2 publications dans cette catégorie
Affiliations :
National Institute for Longevity Sciences, National Center for Geriatrics and Gerontology, Aichi, Japan.
Publications dans "Indoleamine-pyrrole 2,3,-dioxygenase" :
2 publications dans cette catégorie
Affiliations :
Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
Publications dans "Indoleamine-pyrrole 2,3,-dioxygenase" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical Analysis and Toxicology, School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
Publications dans "Indoleamine-pyrrole 2,3,-dioxygenase" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical Analysis and Toxicology, School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
Publications dans "Indoleamine-pyrrole 2,3,-dioxygenase" :
2 publications dans cette catégorie
Affiliations :
Quantitative Biosciences, Merck & Co, Inc., Boston, MA, USA.
Publications dans "Indoleamine-pyrrole 2,3,-dioxygenase" :
2 publications dans cette catégorie
Affiliations :
Protein Production and Structure Core Facility, School of Life Sciences , École Polytechnique Fédérale de Lausanne (EPFL) , 1015 Lausanne , Switzerland.
Publications dans "Indoleamine-pyrrole 2,3,-dioxygenase" :
2 publications dans cette catégorie
Affiliations :
Molecular Modeling Group , SIB Swiss Institute of Bioinformatics , 1015 Lausanne , Switzerland.
Laboratory of Glycochemistry and Asymmetric Synthesis , École Polytechnique Fédérale de Lausanne (EPFL) , 1015 Lausanne , Switzerland.
Publications dans "Indoleamine-pyrrole 2,3,-dioxygenase" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Glycochemistry and Asymmetric Synthesis , École Polytechnique Fédérale de Lausanne (EPFL) , 1015 Lausanne , Switzerland.
Publications dans "Indoleamine-pyrrole 2,3,-dioxygenase" :
2 publications dans cette catégorie
Affiliations :
Protein Production and Structure Core Facility, School of Life Sciences , École Polytechnique Fédérale de Lausanne (EPFL) , 1015 Lausanne , Switzerland.
Publications dans "Indoleamine-pyrrole 2,3,-dioxygenase" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Genetic Engineering, Department of Biochemistry, School of Life Sciences, Fudan University, 2005 Songhu Road, 200438 Shanghai, China. Electronic address: 17110700084@fudan.edu.cn.
Publications dans "Indoleamine-pyrrole 2,3,-dioxygenase" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Genetic Engineering, Department of Biochemistry, School of Life Sciences, Fudan University, 2005 Songhu Road, 200438 Shanghai, China. Electronic address: yangqing68@fudan.edu.cn.
Publications dans "Indoleamine-pyrrole 2,3,-dioxygenase" :
2 publications dans cette catégorie
Affiliations :
Shanghai Key Lab of Chemical Assessment and Sustainability, School of Chemical Science and Engineering, Tongji University, 1239 Siping Road, 200092 Shanghai, China. Electronic address: kuangcx@tongji.edu.cn.
Publications dans "Indoleamine-pyrrole 2,3,-dioxygenase" :
Diquafosol enhances fluid transfer and mucin secretion on ocular surface, which has been suggested as an effective treatment for dry eye disease (DED). The aim of the systematic review and meta-analys...
Relevant randomized controlled trials were obtained via search of electronic including PubMed, Embase, Cochrane Library, and Web of Science. A random-effects model was used to pool the results after i...
A total of nine RCTs involving 1295 patients with DED were included in the meta-analysis. Compared to treatment with 0.1% HA, topical treatment with 3% diquafosol significantly improved the Ocular Sur...
Topical treatment with 3% diquafosol may be more effective than 0.1% HA for patients with DED. However, the long-term efficacy and tolerability of diquafosol still need to be determined....
Narrowband ultraviolet B (NB-UVB) phototherapy is commonly prescribed for patients with moderate-to-severe atopic eczema (AE). The efficacy of NB-UVB, however, has not yet properly been established, a...
A pragmatic, multicenter, PROBE trial will be performed with 1:1 randomization of 316 adult patients with moderate-to-severe AE who have inadequate disease control with topical therapy and who are eli...
The UPDATE trial aims to provide high-quality evidence regarding the (cost-)effectiveness and safety of NB-UVB phototherapy in moderate-to-severe AE patients. Challenges that are addressed in the prot...
ClinicalTrials.gov NCT05704205. Registered on December 8, 2022....
Topical drugs are often used as first-line treatment for dermatological conditions. A within-person design may then be well adapted: it consists of randomizing lesions/body sites rather than patients,...
The aim of this review was to provide a methodological overview of within-person randomized trials (WP-RCTs) in dermatology....
We searched for eligible trials published between 2017 and 2021 in MEDLINE, Embase, and Central in dermatology journals and the 6 highest-impact-factor general medical journals. Two authors selected p...
From 1,034 articles identified, we included 54 WP-RCTs, mainly for acne vulgaris, psoriasis, actinic keratosis, and atopic dermatitis. In most of the trials, patients had only 2 lesions/body sites. In...
Our systematic review highlights that despite the publication of the CONSORT checklist extension for WP-RCTs in 2017, this design is rarely used, and when it is, there are methodological and reporting...
We aim to evaluate the clinical efficacy and safety of using laser and light combined with topical minoxidil for alopecia areata. We searched PubMed, Embase, Web of Science, the Cochrane Library, Chin...
Vulvar lichen sclerosus (LS) is a chronic debilitating inflammatory skin disease. Today, the gold standard is a life-long topical steroid treatment. Alternative options are highly desired. We present ...
We recruited 66 patients, 44 in the laser arm and 22 in the steroid arm. Patients with a physician-administered clinical LS score ≥ 4 were included. Participants received either four laser treatments ...
The findings of this trial have the potential to offer a novel treatment option for LS. The standardized Nd:YAG/Er:YAG laser settings and the treatment regime are presented in this paper....
NCT03926299....
Alopecia areata (AA) is a common autoimmune skin disease. Our study aimed to systematically evaluate the efficacy and safety of compound glycyrrhizin (CG) combined with topical minoxidil therapy in tr...
We searched the PubMed, EMBASE, Cochrane Library, Web of Science, CNKI, Wanfang, and VIP databases. Randomized controlled trials (RCTs) on CG combined with topical minoxidil therapy compared with topi...
11 RCTs and 1189 patients were included. Compared with topical minoxidil therapy alone, CG combined with topical minoxidil therapy was more effective at improving the clinical efficacy (RR = 1.36, 95%...
The current evidence indicates that CG combined with topical minoxidil therapy is effective and safe for AA. However, owing to the suboptimal quality of the included studies, more high-quality and lar...
The purpose was to identify and summarize the existing evidence on the efficacy and safety of the topical application of olive oil for preventing pressure ulcers (PUs). We included only randomized con...
To investigate the clinical efficacy and safety of topical difamilast in mild-to-moderate atopic dermatitis (AD)....
Only randomized controlled trials (RCTs) that compared topical difamilast with vehicle treatment for patients with AD were included. PubMed, Web of Science, Ovid Medline, Cochrane Library, ClinicalTri...
Five studies enrolling a total of 1009 patients with mild-to-moderate AD were identified. Compared with the topical vehicle, topical difamilast was associated with a significantly higher success rate ...
This meta-analysis suggests that topical difamilast is an effective and safe treatment for mild-to-moderate AD....
Melasma is a chronic relapsing skin condition. Laser therapy is a new advancement in treatment. Whether the topical application of tranexamic acid (TXA) increases the efficacy of laser therapy in mela...
Randomized controlled trials are used to estimate the causal effect of a treatment on a health outcome of interest in a patient population. Often the specified treatment in a randomized controlled tri...
We use causal reasoning to explain why randomized controlled trials of biomarker targets can arrive at conflicting or misleading conclusions. We describe four key threats to the validity of trials of ...
We illustrate these findings using evidence from 15 randomized controlled trials of blood pressure targets for management of hypertension. Randomized trials of blood pressure targets exhibit substanti...
Researchers should critically assess meta-analyses of trials of targets for variation in the types, distributions, and off-target effects of therapies studied. Trial investigators should release detai...